Dorotea D - Search Results

1

A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats.

Dorotea D, Kwon G, Lee JH, Saunders E, Bae YS, Moon SH, Lee SJ, Cha DR, Ha H. Dorotea D, et al. Pharmacology. 2018;102(3-4):180-189. doi: 10.1159/000491398. Epub 2018 Aug 10. Pharmacology. 2018. PMID: 30099457

2

Orally active, species-independent novel A₃ adenosine receptor antagonist protects against kidney injury in db/db mice.

Dorotea D, Cho A, Lee G, Kwon G, Lee J, Sahu PK, Jeong LS, Cha DR, Ha H. Dorotea D, et al. Exp Mol Med. 2018 Apr 20;50(4):1-14. doi: 10.1038/s12276-018-0053-x. Exp Mol Med. 2018. PMID: 29674631 Free PMC article.

3

Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress.

Dorotea D, Jiang S, Pak ES, Son JB, Choi HG, Ahn SM, Ha H. Dorotea D, et al. Exp Mol Med. 2022 Aug;54(8):1086-1097. doi: 10.1038/s12276-022-00810-3. Epub 2022 Aug 2. Exp Mol Med. 2022. PMID: 35918533 Free PMC article.

4

Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways.

Dorotea D, Koya D, Ha H. Dorotea D, et al. Front Pharmacol. 2020 Mar 17;11:265. doi: 10.3389/fphar.2020.00265. eCollection 2020. Front Pharmacol. 2020. PMID: 32256356 Free PMC article. Review.

5

Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury.

Uddin MJ, Dorotea D, Pak ES, Ha H. Uddin MJ, et al. Among authors: dorotea d. Biomol Ther (Seoul). 2020 May 1;28(3):213-221. doi: 10.4062/biomolther.2019.214. Biomol Ther (Seoul). 2020. PMID: 32336052 Free PMC article. Review.

6

Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk.

Jiang S, Oh DS, Dorotea D, Son E, Kim DS, Ha H. Jiang S, et al. Among authors: dorotea d. Phytomedicine. 2021 Jan;80:153393. doi: 10.1016/j.phymed.2020.153393. Epub 2020 Oct 17. Phytomedicine. 2021. PMID: 33120292

7

Activation of β₂ adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases.

Dorotea D, Ha H. Dorotea D, et al. Arch Pharm Res. 2021 Jan;44(1):49-62. doi: 10.1007/s12272-020-01280-9. Epub 2020 Nov 5. Arch Pharm Res. 2021. PMID: 33155167 Review.

8

KF-1607, a Novel Pan Src Kinase Inhibitor, Attenuates Obstruction-Induced Tubulointerstitial Fibrosis in Mice.

Dorotea D, Lee S, Lee SJ, Lee G, Son JB, Choi HG, Ahn SM, Ha H. Dorotea D, et al. Biomol Ther (Seoul). 2021 Jan 1;29(1):41-51. doi: 10.4062/biomolther.2020.088. Biomol Ther (Seoul). 2021. PMID: 32690822 Free PMC article.

9

TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease.

Lee SM, Dorotea D, Jung I, Nakabayashi T, Miyata T, Ha H. Lee SM, et al. Among authors: dorotea d. Oncotarget. 2017 Sep 21;8(52):89746-89760. doi: 10.18632/oncotarget.21120. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163785 Free PMC article.

10

Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress.

Piao L, Dorotea D, Jiang S, Koh EH, Oh GT, Ha H. Piao L, et al. Among authors: dorotea d. Antioxid Redox Signal. 2019 Dec 20;31(18):1339-1351. doi: 10.1089/ars.2018.7614. Antioxid Redox Signal. 2019. PMID: 31530170 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters